Inventor · disambiguated record
Xin Hu
Also filed as: HU XIN
14 granted patents·6 pending applications·19 citations·filing 2014–2025
87Inventor score
Files withUS HEALTH10THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES3UNIV JOHNS HOPKINS3NAT INSTITUTES OF HEALTH UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES1THE US SECRETARY DEPARTMENT OF HEALTH1
Top patents by PatentIndex Score
20 records- 0194US11247971B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2021·Granted Feb 15, 2022·3 cites·17 claims
- 0290US10961200B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofTHE US SECRETARY DEPARTMENT OF HEALTH·Filed 2019·Granted Mar 30, 2021·4 cites·18 claims
- 0389US10351532B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUNIV VANDERBILT·Filed 2015·Granted Jul 16, 2019·8 cites·21 claims
- 0486US12365653B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2024·Granted Jul 22, 2025·0 cites·12 claims
- 0583US11253511B2Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)UNIV JOHNS HOPKINS·Filed 2017·Granted Feb 22, 2022·2 cites·4 claims
- 0676US11897845B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2022·Granted Feb 13, 2024·0 cites·19 claims
- 0776US2025340521A1C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 0873US12435047B2c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Oct 7, 2025·0 cites·19 claims
- 0973US10954228B21 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereofNAT INSTITUTES OF HEALTH UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Mar 23, 2021·2 cites·18 claims
- 1071US12145922B2Selective D3 dopamine receptor agonists and methods of their useUS HEALTH·Filed 2023·Granted Nov 19, 2024·0 cites·21 claims
- 1170US12208093B2Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)UNIV JOHNS HOPKINS·Filed 2022·Granted Jan 28, 2025·0 cites·4 claims
- 1259US2025134907A1Fused diazepines as agonists of the insulin-like 3 (insl3) peptide receptor rxfp2 and methods of use thereofUS HEALTH·Filed 2023·Application pending·0 cites
- 1358US11649218B2C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted May 16, 2023·0 cites·18 claims
- 1457US11766423B22,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseasesUNIV JOHNS HOPKINS·Filed 2019·Granted Sep 26, 2023·0 cites·2 claims
- 1555US11634404B2Selective D3 dopamine receptor agonists and methods of their useUS HEALTH·Filed 2017·Granted Apr 25, 2023·0 cites·16 claims
- 1654US2024336604A1D3 dopamine receptor-selective negative allosteric modulatorsUS HEALTH·Filed 2022·Application pending·0 cites
- 1752US2022315548A1Small molecule agonists of mucolipin 1 and uses thereofUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 1844US2023056497A1CD206 Modulators Their Use and Methods for PreparationUS HEALTH·Filed 2020·Application pending·0 cites
- 1942US2017001988A1Piperidine and piperazine derivatives and their use in treating viral infections and cancerUS HEALTH·Filed 2014·Application pending·0 cites
- 2032US10202367B2Heterocyclic compounds and methods of use thereofUS HEALTH·Filed 2015·Granted Feb 12, 2019·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Xin Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →